Commitments and Contingencies (Details) |
3 Months Ended | |||||
|---|---|---|---|---|---|---|
|
Feb. 24, 2022
USD ($)
|
Sep. 20, 2021
USD ($)
|
Sep. 03, 2021 |
Sep. 01, 2021
USD ($)
|
Mar. 31, 2023
USD ($)
|
Mar. 31, 2023
CAD ($)
|
|
| Commitments and Contingencies (Details) [Line Items] | ||||||
| Compensatory damages in excess | $ 11,286,570 | |||||
| Principal amount | $ 371,178 | |||||
| Additional amount | $ 300,000 | |||||
| Interest accruing | $ 6,776,686 | |||||
| Commitments combined amount | 3,248,696 | $ 4,395,000 | ||||
| Additional sum of amount | $ 2,721,036 | |||||
| Settlement paying amount | $ 2,000,000 | |||||
| Consulting Agreement [Member] | ||||||
| Commitments and Contingencies (Details) [Line Items] | ||||||
| Related party transaction, description | The Company records liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. | The Company records liabilities for loss contingencies arising from claims, assessments, litigation, fines, penalties and other sources when it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. | ||||
| Stanford [Member] | ||||||
| Commitments and Contingencies (Details) [Line Items] | ||||||
| Related party transaction, description | On or about September 3, 2021, Dr. Krauss filed an Amended and Supplemental Complaint (the “Amended Complaint”) in this action, which added the further claims that Dr. Krauss is also allegedly entitled to advancement by the Company of her expenses, including attorney’s fees, for the costs of defending against the Third-Party Complaint in the Tyche Capital LLC action referenced below, and the costs of defending against the Company’s own Complaint against Dr. Krauss as described above. | |||||
| Oxford [Member] | CBR [Member] | ||||||
| Commitments and Contingencies (Details) [Line Items] | ||||||
| Related party transaction, description | On or about September 23, 2021, the Company filed its Answer to the Amended Complaint in which the Company denied each of Dr. Krauss’ claims and further raised numerous affirmative defenses with respect thereto. | |||||
| Yissum [Member] | CBR [Member] | ||||||
| Commitments and Contingencies (Details) [Line Items] | ||||||
| Underwriting commitments, description | The Company is seeking payment for a substantial portion of such amounts from its director and officers’ insurance policy, of which no assurance can be provided that the directors and officers insurance policy will cover such amounts. | The Company is seeking payment for a substantial portion of such amounts from its director and officers’ insurance policy, of which no assurance can be provided that the directors and officers insurance policy will cover such amounts. | ||||